A PYMNTS Company

Japan: Fujifilm makes $800m biotech acquisition

By  |  April 5, 2018

Japan-based Fujifilm has revealed its plan to acquire two cell-culture media companies for US$800 million. Last week, Fujifilm announced that it would buy firm Irvine Scientific Sales and related biotech unit IS Japan from JXTG.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Culture media contain the nutrients required for the growth and proliferation of cells. According to Fujifilm they are “essential” for cell culturing in the research and development and manufacturing of biopharmaceuticals and regenerative medicine products.

    The company said in a statement that the acquisitions combined with Fujifilm’s bio-medical-related technologies will help “further expansion of the contact development and manufacturing business for biopharmaceuticals, the acceleration of research and development in the area of regenerative medicine, and the further expansion of reagent business.”

    Full Content: Fierce Pharma

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.